Long‐term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer?

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Surgical Oncology

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1096-9098(200005)74:1<15::AID-JSO4>3.0.CO;2-ZPMID 10861602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms.

  1998cited by this paper
• Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis

  1997cited by this paper
• Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis

  1996cited by this paper
• Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.

  1996cited by this paper
• Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

  1995cited by this paper
• Rectal cancer after prolonged sulindac chemoprevention. A case report

  1995cited by this paper
• The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.

  1995cited by this paper
• Early detection of nonpolypoid cancers in the rectal remnant in patients with familial adenomatous polyposis/gardner's syndrome

  1994cited by this paper
• Substance P attenuates gastric mucosal hyperemia after stimulation of sensory neurons in the rat stomach.

  1994cited by this paper
• Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.

  1994cited by this paper
• Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy.

  1994cited by this paper
• Minute adenomas of the depressed type in familial adenomatous polyposis of the colon. A pathway to ordinary polypoid adenomas

  1993cited by this paper
• The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration

  1993cited by this paper
• The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.

  1993cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis

  1993cited by this paper
• Epidemiologic characteristics of the flat adenoma of muto

  1992cited by this paper
• Hereditary flat adenoma syndrome: A variant of familial adenomatous polyposis?

  1992cited by this paper
• Early depressed adenocarcinomas of the large intestine

  1992cited by this paper
• Rectal cancer risk in patients treated for familial adenomatous polyposis

  1992cited by this paper
• Sulindac causes regression of rectal polyps in familial adenomatous polyposis.

  1991cited by this paper
• Effects of long-term sulindac therapy on colonic polyposis.

  1991cited by this paper
• Sulindac suppression of colorectal polyps in Gardner's syndrome.

  1990cited by this paper
• [Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac].

  1990cited by this paper
• Sulindac suppression of colorectal polyps in Gardner's syndrome.

  1990cited by this paper
• Histogenesis of tubular adenomas in hereditary colonic adenomatous polyposis.

  1989cited by this paper
• Sulindac for polyposis of the colon.

  1989cited by this paper
• Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat.

  1989cited by this paper
• Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects.

  1988cited by this paper
• Mucin abnormality in colonic mucosa in patients with familial polyposis coli.

  1987cited by this paper
• The rectum in adenomatous polyposis: the St. Mark's policy

  1986cited by this paper
• [Efficacy of sulindac in the treatment of rectocolic polyposis].

  1986cited by this paper
• [Necrotizing vasculitis and villous atrophy of the small intestine].

  1986cited by this paper
• Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors.

  1986cited by this paper
• Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors.

  1986cited by this paper
• The rectum in adenomatous polyposis: the St. Mark's policy.

  1985cited by this paper
• Sulindac treatment for familial polyposis coli.

  1985cited by this paper
• Small “flat adenoma” of the large bowel with special reference to its clinicopathologic features

  1985cited by this paper
• Pathogenesis of polyps (adenomas)

  1983cited by this paper
• Sulindac for polyposis of the colon

  1983cited by this paper
• Rectal cancer following colectomy for polyposis.

  1980cited by this paper
• Proliferative patterns in colonic mucosa in familial polyposis

  1975cited by this paper

• Chemoprevention in Inherited Colorectal Cancer Syndromes

  2023cites this paper
• Biology of Pre-cancers and Opportunities for Cancer Interception - lesson from colorectal cancer susceptibility syndromes.

  2023cites this paper
• Chemoprevention in hereditary digestive neoplasia: A comprehensive review

  2023cites this paper
• Chinese consensus on prevention of colorectal neoplasia (2021, Shanghai)

  2022cites this paper
• Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study

  2022cites this paper
• Regular endoscopic surveillance and polypectomy is effective in managing rectal adenoma progression following colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis

  2021cites this paper
• Prophylactic Surgery: Why, When, and How?

  2021cites this paper
• Familial adenomatous polyposis, diagnosis and surveillance strategies: review article

  2020cites this paper
• Management of Familial Adenomatous Polyposis in Children and Adolescents: Position Paper From the ESPGHAN Polyposis Working Group.

  2019cites this paper
• Cancer prevention in hereditary colorectal cancer syndromes: Chemoprevention and lifestyle changes

  2018cites this paper
• Complete Regression of the Adenomatous Polyps in a Patient affected by Familial Adenomatous Polyposis after Prolonged Administration of Phytoestrogens and Sulindac

  2018cites this paper
• Low intestinal tract adenomatous polyps regression in FAP patients by dietary-induced erbeta upregulatior

  2018cites this paper
• Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas

  2017cites this paper
• Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?

  2017cites this paper
• Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

  2016cites this paper
• Clinical Effects of NSAIDs and COXIBs in Colon Cancer Prevention

  2016cites this paper
• Prophylactic colectomy: Rationale, indications, and approach

  2015cites this paper
• Positive Effekte von NSAR auf den Gastrointestinaltrakt

  2015cites this paper
• Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update

  2014cites this paper
• Regression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy

  2014cites this paper
• Chemoprevention of Colorectal Cancer

  2014cites this paper
• Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.

  2013cites this paper
• Adjuvant Treatment and Predictors of Response in Colon Cancer

  2011cites this paper
• The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP

  2011cites this paper
• Inherited Syndromes Predisposing to Inflammation and GI Cancer.

  2011cites this paper
• Chemoprevention in familial adenomatous polyposis.

  2011cites this paper
• Alterations Associated with Sulindac-Resistant Pr R on Tumors in Apc Min / + Mice

  2010cites this paper
• Mouse models of inherited cancer syndromes.

  2010cites this paper
• Molecular Alterations Associated with Sulindac-Resistant Colon Tumors in ApcMin/+ Mice

  2010cites this paper
• The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1/MIC-1/PTGF-beta).

  2010cites this paper
• Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.

  2009cites this paper
• Recognition and management of hereditary colorectal cancer syndromes.

  2009cites this paper
• Colonic Adenomatous Polyposis Syndromes: Clinical Management

  2008cites this paper
• Colonic adenomatous polyposis syndromes: clinical management.

  2008cites this paper
• [Follow-up after surgical treatment of patients with familial adenomatous polyposis: results in a southern Spanish population].

  2007cites this paper
• Spontaneous regression of rectal polyps following abdominal colectomy and ileorectal anastomosis for familial adenomatous polyposis, without sulindac treatment: report of four cases.

  2007cites this paper
• Seguimiento posquirúrgico de los pacientes con poliposis adenomatosa familiar: resultados en una población del sur de España

  2007cites this paper
• Spontaneous regression of rectal polyps following abdominal colectomy and ileorectal anastomosis for familial adenomatous polyposis, without sulindac treatment: Report of four cases

  2007cites this paper
• Effect of the non‐steroidal anti‐inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis

  2006cites this paper
• ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.

  2006cites this paper
• ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes

  2006cites this paper
• Familial Adenomatous Polyposis

  2006cites this paper
• Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.

  2006cites this paper
• Chemoprevention of Colorectal Cancer

  2006cites this paper
• Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy.

  2005cites this paper
• Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.

  2005cites this paper
• Can a marker be a surrogate for development of cancer, and would we know it if it exists?

  2005cites this paper
• Inherited Colorectal Cancer Syndromes

  2005cites this paper
• Sulindac sulfide–induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2

  2005cites this paper
• [Surgical strategies for the prevention of gastrointestinal tumours].

  2005cites this paper
• Ileoanal Pouch Neoplasia in Familial Adenomatous Polyposis: An Underestimated Threat

  2005cites this paper
• Chirurgische Ansätze zur Prävention bei gastrointestinalen Tumoren

  2005cites this paper
• Chirurgische Prävention bei HereditärenKrebssyndromen

  2004cites this paper
• Mouse Models of Human Familial Cancer Syndromes

  2004cites this paper
• Hereditary cancer: guidelines in clinical practice--general overview.

  2004cites this paper
• Sporadisches und hereditäres Karzinom von Kolon und Rektum

  2003cites this paper
• Chemopreventive Strategies Using NSAIDs and COX-2 Inhibitors

  2003cites this paper
• Cyclooxygenase inhibitors: drugs for cancer prevention.

  2003cites this paper
• [Sporadic and hereditary colorectal cancer. Pathogenetically different with different therapeutic indications].

  2003cites this paper
• Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer).

  2003influential citation
• Rofecoxib Reduces Polyp Recurrence in Familial Polyposis

  2003cites this paper
• ALIMENTARY TRACT: CLINICAL REVIEW Cyclo-Oxygenase Inhibition in Colorectal Adenomas and Cancer

  2003cites this paper
• Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.

  2003cites this paper
• Hereditary colorectal cancer.

  2003cites this paper
• Radioprotection: the non‐steroidal anti‐inflammatory drugs (NSAIDs) and prostaglandins

  2002cites this paper
• Cancer Prevention by Delay

  2002cites this paper
• [Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories].

  2002cites this paper
• Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.

  2002cites this paper
• Primary chemoprevention of familial adenomatous polyposis with sulindac.

  2002cites this paper
• Non-cancerous ophthalmic clues to non-ocular cancer.

  2002cites this paper
• Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

  2002influential citation
• The Role of Eicosanoids, Cyclooxygenases, and Nonsteroidal Anti‐inflammatory Drugs in Colorectal Tumorigenesis and Chemoprevention

  2002cites this paper
• Entwicklung eines Rektumkarzinoms bei familiärer adenomatöser Polyposis coli nach ileorektaler Anastomose und lokoregionaler Chemoprävention mit Sulindac

  2002cites this paper
• Primary chemoprevention of familial adenomatous polyposis with sulindac

  2002cites this paper
• Complete regression of colonic adenomas after treatment with sulindac in Gardner's syndrome: a 4-year follow-up

  2001cites this paper
• Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.

  2001cites this paper
• [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].

  2001cites this paper
• Rationnel et perspectives d'utilisation des inhibiteurs de cyclooxygénase-2 (COX-2) dans les cancers colorectaux

  2001cites this paper